Our Mission
To unlock the transformative power of Chemoproteomics and AI in revolutionizing drug discovery, making the process faster, more efficient, and more precise.
Our Approach
We leverage cutting-edge artificial intelligence technologies to understand protein-ligand interactions at an unprecedented scale. By combining computational methods with experimental validation, we accelerate every stage of the drug discovery process:
- Target Identification: Using AI to discover novel therapeutic targets
- Lead Discovery: Applying chemoproteomics to identify promising drug candidates
- Drug Repurposing: Finding new uses for existing drugs
- Mechanism Understanding: Elucidating how drugs interact with their targets
Our Platform
Our integrated platform combines three powerful technologies:
- Glance: Comprehensive biomedical database for target identification and drug repurposing
- Skeleton: AI research platform for model development and validation
- Javelin: AI-assisted chemoproteomics platform for protein target exploration
Our Vision
We envision a future where drug discovery is dramatically accelerated through the seamless integration of artificial intelligence and experimental biology. By reducing the time and cost of bringing new therapeutics to patients, we aim to make a meaningful impact on human health.
Contact Us
Interested in learning more about Bionsight? We'd love to hear from you.
Email: contact@bionsight.com